Bosh sahifa102460 ā¢ KRX
add
Reyon Pharmaceutical Co Ltd
Yopilish kursi
10Ā 840,00Ā ā©
Kunlik diapazon
10Ā 750,00Ā ā© - 10Ā 930,00Ā ā©
Yillik diapazon
9Ā 830,00Ā ā© - 18Ā 650,00Ā ā©
Bozor kapitalizatsiyasi
201,67Ā mlrd KRW
OŹ»rtacha hajm
11,34Ā ming
Narx/foyda
49,24
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 37,31Ā mlrd | -3,97% |
Joriy xarajat | 20,97Ā mlrd | 20,62% |
Sof foyda | 2,55Ā mlrd | 357,35% |
Sof foyda marjasi | 6,82 | 367,45% |
Har bir ulushga tushum | ā | ā |
EBITDA | -98,25Ā mln | -103,62% |
Amaldagi soliq stavkasi | 5,15% | ā |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 10,21Ā mlrd | -57,86% |
Jami aktivlari | 499,99Ā mlrd | 0,04% |
Jami passivlari | 250,05Ā mlrd | -0,44% |
Umumiy kapital | 249,94Ā mlrd | ā |
Tarqatilgan aksiyalar | 18,34Ā mln | ā |
Narxi/balansdagi bahosi | 0,80 | ā |
Aktivlardan daromad | -1,71% | ā |
Kapitaldan daromad | -1,99% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (KRW) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 2,55Ā mlrd | 357,35% |
Operatsiyalardan naqd pul | -5,31Ā mlrd | -3Ā 633,45% |
Sarmoyadan naqd pul | 1,78Ā mlrd | 133,05% |
Moliyadan naqd pul | 7,32Ā mlrd | 1Ā 889,01% |
Naqd pulning sof oŹ»zgarishi | 3,79Ā mlrd | 163,63% |
BoŹ»sh pul | -50,48Ā mlrd | -769,28% |
Haqida
Tashkil etilgan
1955
Sayt
Xodimlar soni
448
